Dandelion root extract affects colorectal cancer proliferation and survival through the activation of multiple death signalling pathways
Metrics: PDF 1177 views | HTML 420 views | ?
Pamela Ovadje1, Saleem Ammar2, Jose-Antonio Guerrero2,3, John Thor Arnason2, Siyaram Pandey1
1Department of Chemistry & Biochemistry, University of Windsor, Windsor ON, Canada
2Department of Biology, University of Ottawa, Ottawa ON, Canada
3Red de Estudios Moleculares Avanzados, Instituto de Ecología A.C. Xalapa, Veracruz, México
Siyaram Pandey, email: firstname.lastname@example.org
Keywords: cancer, oxidative stress, phytochemical composition, gene expression, natural health product
Received: November 30, 2015 Accepted: July 26, 2016 Published: August 22, 2016
Dandelion extracts have been studied extensively in recent years for its anti-depressant and anti-inflammatory activity. Recent work from our lab, with in-vitro systems, shows the anti-cancer potential of an aqueous dandelion root extract (DRE) in several cancer cell models, with no toxicity to non-cancer cells. In this study, we examined the cancer cell-killing effectiveness of an aqueous DRE in colon cancer cell models. Aqueous DRE induced programmed cell death (PCD) selectively in > 95% of colon cancer cells, irrespective of their p53 status, by 48 hours of treatment. The anti-cancer efficacy of this extract was confirmed in in-vivo studies, as the oral administration of DRE retarded the growth of human colon xenograft models by more than 90%. We found the activation of multiple death pathways in cancer cells by DRE treatment, as revealed by gene expression analyses showing the expression of genes implicated in programmed cell death. Phytochemical analyses of the extract showed complex multi-component composition of the DRE, including some known bioactive phytochemicals such as α-amyrin, β-amyrin, lupeol and taraxasterol. This suggested that this natural extract could engage and effectively target multiple vulnerabilities of cancer cells. Therefore, DRE could be a non-toxic and effective anti-cancer alternative, instrumental for reducing the occurrence of cancer cells drug-resistance.
John Thor Arnason
Primary Contact _
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.